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LETTERS TO THE EDITORRegarding “Cerebral hemodynamic beneﬁts after
carotid artery stenting in patients with near occlusion”
In this very interesting study by Oka et al,1 the authors inves-
tigated cerebral hemodynamics in patients with near occlusion
(NO) and severe carotid stenosis ($70%) before and after carotid
artery stenting (CAS). Cerebral blood ﬂow (CBF) and cerebrovas-
cular reactivity (CVR) were measured using single-photon emis-
sion computed tomography. After CAS, the mean resting CBF
and mean CVR were both signiﬁcantly increased for patients
with NO. In patients without NO, CVR increased signiﬁcantly af-
ter CAS, and the mean resting CBF showed a tendency for an in-
crease, but this was not signiﬁcant.1
Exhausted CVR reﬂects a situation where reduction of perfu-
sion pressure leads to maximal cerebral vasodilatation. Reduced
perfusion also induces impaired clearance of embolic material,
increasing the risk of clinically manifested cerebral ischemia.
Embolization and reduced vasodilatation act synergistically:
when the capacity for cerebral vasodilatation is exhausted, emboli
may more easily produce symptoms.2,3 Preoperative examination
of the CVR helps to identify patients at increased risk for cerebral
ischemia and hyperperfusion syndrome after CAS.2-5 In the study
by Oka et al,1 it would be useful to know if patients with and
without NO who developed neurologic complications after CAS,
attributed to both ischemia and hyperperfusion injury, had a pre-
operative exhausted CVR.
Stress tests used to examine vascular reserves help therapeutic
decisions in patients with coronary or peripheral artery disease.
Management of patients with extracranial carotid artery disease is
practically based on the percentage of stenosis and symptom-
atology, whereas CVR is a physiologic parameter that is often
underevaluated. The examination of CVR increases our knowledge
about the hemodynamic consequences of carotid narrowing and
may help us to recognize patients at increased risk for complica-
tions during carotid revascularization.
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Thank you for your kind letter. Two patients in our series
developed minor ischemic stroke during the perioperative period.
Before carotid artery stenting (CAS), their resting cerebral blood
ﬂow and cerebrovascular reactivity (CVR) on the ipsilateral side
of the middle cerebral artery area were 26.57 mL/100 g/min
and 19.5% (for the near occlusion patient) and 28.98 mL/100
g/min and 28.5% (for the patient without near occlusion), respec-
tively. Therefore, from our experience, exhausted CVR did not
correlate with the ischemic cerebrovascular event after CAS.
As you indicated in your letter, exhausted CVR may be one of
the risk factors for embolism, althoughmanyother factors, including
plaque characteristics, lesion length, patient’s age, stent design, and
so on, may also be involved, and those risk factors may be more
attributable to ischemic complications after CAS.1-3 However, the
patient who developed asymptomatic subarachnoid hemorrhage in
our series exhibited exhausted CVR before CAS, with resting cere-
bral blood ﬂow of 16.95mL/100 g/min and CVR of0.3% on the
ipsilateral side of the middle cerebral artery.
Many previous studies have reported that the risk of hyperper-
fusion after carotid revascularization is high in patients with severe
hemodynamic compromise.4-6 Fromour series and previous studies,
exhausted CVR appears to be more attributable to hyperperfusion
injury. Therefore, we believe that the preoperative examination of
cerebral hemodynamics is more useful to predict the risk of hyper-
perfusion injury than the risk of ischemic event(s) after CAS.
Fumiaki Oka, MD, PhD
Department of Neurosurgery
Yamaguchi University School of Medicine
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Regarding “Thoracic endovascular aneurysm repair,
race, and volume in thoracic aneurysm repair”
We read with great interest the article by Goodney et al1 in the
January 2013 issue of the Journal of Vascular Surgery. The authors571
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outcome and identify race-correlated disparities in access to high-
volume surgical centers as a potential contributor to higher post-
operative mortality among black patients. This is an important
insight, and one that should be of concern for health care resource
planning as health care reform moves forward.
The authors go on to comment that, although clear volume
effects are apparent for race and open surgical mortalitydlow vol-
ume being associated with bothdno such effects are present for
thoracic endovascular aortic repair (TEVAR). Furthermore, the
authors show that TEVAR patients of white and black race have
nearly identical mortality curves during 5 years of follow-up, and
indeed, the log-rank test shows no difference between the groups
(P < .563). From this, they conclude that TEVAR may produce
less racial disparity in outcome.
Unfortunately, elimination of the racial disparity in survival
seems to be accomplished by reducing 5-year survival in white
and black patients alike. At year 5 in the surgery group, survival
is 71% for whites and 61% for blacks, whereas in the TEVAR
group, it appears to bew56% for both whites and blacks. The au-
thors do say in the Results that “Overall, patients with intact TAAs
selected for TEVAR had poorer 5-year survival..,” implying that
the higher 5-year mortality rate is merely a selection effect, but we
do not see a test of selection to TEVAR in the report. Moreover,
survival at 30 days is comparable between TEVAR and open repair
patients (93.9% vs 92.9%, respectively; P ¼ .563), which suggests
that the poorer outcome in TEVAR patients occurred later in the
postoperative course than in the perioperative period. No informa-
tion on postoperative events, such as reinterventions, that might
assist in interpreting the steeper late mortality slope is presented.
Taken at face value, the results of their report suggest that the
way to reduce racial disparities in outcome is to offer an inferior
treatment to everyone. Without more actual information on pre-
operative characteristics that would suggest a selection biasdor
late reinterventions that might suggest a stormy late coursedit is
impossible to tell why everyone did worse with TEVAR. Based
solely on the data presented, it is difﬁcult to see any support for
a recommendation that TEVAR is a preferred strategy for the
reduction of race-correlated outcome disparities.
Charles C. Miller III, PhD
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Reply
We appreciate the editorialist’s interest in our manuscript and
our ﬁndings. The editorialist makes two very accurate assertions:
(1) that long-term survival is inferior among all patients undergo-
ing thoracic endovascular aortic repair (TEVAR), both black andwhite, and (2) deaths occurring after 30 days appear to drive the
long-term difference in survival between patients selected for
open repair and patients selected for TEVAR, an effect that is again
independent of race.
Why do patients selected for TEVAR fare worse over time
than patients selected for open surgical repair of thoracoabdominal
aortic aneurysm? Our prior research performed some of the “tests
of selection” insightfully described by the editorialist.1 In crude,
risk-adjusted, and propensity-matched models, patients selected
for TEVAR always fared worse in long-term survival. And while
analyses of secondary reintervention are possible explanations, we
suspect that our future work will show that surgeons are simply
performing TEVAR on sicker patients who, in ways not easily
measurable in administrative claims, are less likely to beneﬁt from
the procedure in the long-term.
But, for several reasons, we respectfully disagree that poorer
late survival after TEVAR means that that we are “offering an infe-
rior treatment to everyone.” First, black patients have poorer out-
comes with open repair, both in the short and long-term, because
they tend to receive repair in the lowest volume institutions. This
effect entirely disappears e for both short- and long-term out-
comes e when the operation is performed using TEVAR, where
little volume-outcome effect is apparent. Second, the editorialist’s
emphasis on long-term survival as the only outcome of interest
suggests that only low-risk patients e those likely to have good
long-term survival e should undergo TEVAR. This strategy could
have unintended consequences, such as diverting high-risk patients
towards open repair, further exacerbating race-dependent volume-
outcome differences. And ﬁnally, epidemiologic differences aside,
one only has to make rounds on a few patients on the ﬁrst postop-
erative day after thoracic aneurysm repair to recognize the short-
term beneﬁts of the less invasive approach.
Overall, we agree entirely that more work is needed to
better identify those patients e both black and white, high- and
low-risk e who will derive long-term beneﬁt from TEVAR. While
we appreciate the editorialist’s viewpoint, we respectfully suggest
that they not “throw the baby out with the bathwater.” The
knowledge gaps they describe need not obviate our suggestion
that a simpler operation e one that can be broadly disseminated
in disadvantaged populations e may be the best solution towards
limiting racial disparities in surgical care.
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